From clots to cuts in antiphospholipid syndrome.

Reumatol Clin (Engl Ed)

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Tel-Aviv, Israel; Reichman University, Herzliya, Israel.

Published: May 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.reumae.2024.05.001DOI Listing

Publication Analysis

Top Keywords

clots cuts
4
cuts antiphospholipid
4
antiphospholipid syndrome
4
clots
1
antiphospholipid
1
syndrome
1

Similar Publications

From clots to cuts in antiphospholipid syndrome.

Reumatol Clin (Engl Ed)

May 2024

Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Ramat Gan, Tel-Aviv, Israel; Reichman University, Herzliya, Israel.

View Article and Find Full Text PDF

Hemostasis, the process of normal physiological control of vascular damage, is fundamental to human life. We all suffer minor cuts and puncture wounds from time to time. In hemostasis, self-limiting platelet aggregation leads to the formation of a structured thrombus in which bleeding cessation comes from capping the hole from the outside.

View Article and Find Full Text PDF

Afibrinogenemia is a coagulation disorder that occurs with a frequency of 1-2 cases/1,000,000 population and is characterized by a lack of capacity to synthesize fibrinogen. The predominant symptoms related to fibrinogen deficiency are mucocutaneous bleeding, bleeding from the gastrointestinal tract, genital tract or other vascularized tissues as well as excessive bleeding after minor injuries or accidental cuts. Thromboembolic complications and impaired wound healing may also occur.

View Article and Find Full Text PDF

Minimally invasive neurological surgeries are increasingly being sought after for treatment in neurological pathologies and oncology. A critical limitation in these minimally invasive procedures is lack of specialized tools that allow for space-time controlled delivery of sufficient energy for coagulation and cutting of tissue. Advent of fiber-lasers provide high average power with improved beam quality (lower M), biocompatible silica fiber delivery, reduced cost of manufacturing, and radiant output stability over long operating periods.

View Article and Find Full Text PDF

Beyond cuts and scrapes: plasmin in malaria and other vector-borne diseases.

Trends Parasitol

February 2022

Laboratory of Malaria and Vector Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA. Electronic address:

Plasmodium and other vector-borne pathogens have evolved mechanisms to hijack the mammalian fibrinolytic system to facilitate infection of the human host and the invertebrate vector. Plasmin, the effector protease of fibrinolysis, maintains homeostasis in the blood vasculature by degrading the fibrin that forms blood clots. Plasmin also degrades proteins from extracellular matrices, the complement system, and immunoglobulins.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!